(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt - Names and Identifiers
Name | (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt
|
Synonyms | EscitalopraM Related CoMpound A Escitalopram USP Related Compound A (-)-4-(4-Dimethylamino)-1-(4-Fluorophenyl)-1-(Hydroxybuty)-3-Hydroxymethyl)-Benzonitrile Hemi D-(+)-Di-P-Toloyltartaric Acid Salt (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt Escitalopram Related Compound A (10 mg) ((-) 4-[(4-dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybutyl)]-3-(hydroxymethyl) benzonitrile) (S)-4-[4-(DiMethylaMino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxyMethyl)-benzonitrile (2S,3S)-2,3-bis[(4-Methylbenzoyl)oxy]butanedioate
|
CAS | 128173-53-5
|
InChI | InChI=1/2C20H23FN2O2.C20H18O8/c2*1-23(2)11-3-10-20(25,17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24;1-11-3-7-13(8-4-11)19(25)27-15(17(21)22)16(18(23)24)28-20(26)14-9-5-12(2)6-10-14/h2*4-9,12,24-25H,3,10-11,14H2,1-2H3;3-10,15-16H,1-2H3,(H,21,22)(H,23,24)/t2*20-;15-,16-/m000/s1 |
(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt - Physico-chemical Properties
Molecular Formula | 2C20H23FN2O2.C20H18O8
|
Molar Mass | 1071.18 |
Melting Point | 134-135 °C |
Storage Condition | Room Temprature |
(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt - Risk and Safety
(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt - Introduction
D-DTTA salt is a bidentate ligand with the chemical name bis ((2-(3,5-dimethyl-1H-pyrazol-1-yl) ethyl) amino) triacetate. It has some of the following properties:
1. Solubility: D-DTTA salt can be dissolved in water to form a negatively charged salt.
2. Coordination: As a ligand, D-DTTA salts can form stable complexes with metal ions, especially with lanthanide and uranium metals.
D-DTTA salt uses:
1. Environmental analysis: D-DTTA salts can be used for the determination and analysis of trace metal ions in environmental samples, such as groundwater, soil and wastewater samples.
2. Drugs and medicine: D-DTTA salts can be used as labeling agents or active substances of drugs for nuclear medicine imaging, drug delivery research and so on.
D-DTTA salt preparation method:
The synthesis of D-DTTA salts usually involves a multi-step reaction. A common method of preparation is by reaction of the substrate 2-(3,5-dimethyl-1H-pyrazol-1-yl) ethylammonium bromide with triacetic acid to give the D-DTTA salt.
Safety information for D-DTTA salt:
D-DTTA salt because of its toxicity, the use of the need to pay attention to the following safety matters:
1. Avoid contact with skin and eyes, and use safety gloves and goggles when necessary.
2. When using and handling D-DTTA salt, it should be operated in a well-ventilated laboratory environment to avoid inhaling its vapor or dust.
3. swallowing or eating D-DTTA salt may lead to poisoning, if there is an accident, should immediately seek medical attention.
4. Waste disposal should follow local regulations and take appropriate measures to avoid environmental pollution.
Please note that the above information is for reference only. When using D-DTTA salt, you should carefully read the relevant safety data sheets and instructions, and follow the recommendations of professionals.
Last Update:2024-04-09 21:21:28